NCT06152055

Brief Summary

This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 30, 2023

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

12 months

First QC Date

November 21, 2023

Last Update Submit

November 21, 2023

Conditions

Keywords

Head and Neck CancerRadiotherapyChemotherapy

Outcome Measures

Primary Outcomes (5)

  • Age - wise Distribution of Head and Neck Cancers (HNCs)

    Age - wise Distribution of Head and Neck Cancer

    1 year

  • : Distribution of HNCs according to subsite

    Distribution of Head and Neck Cancers according to the subsite

    1 year

  • Histopathology of HNCs

    Histopathology of Head and Neck Cancer

    1 year

  • Tumor, Nodes, Metastasis (TNM) staging of HNC

    Staging at presentation of Head and Neck Cancer

    1 year

  • Treatment provided to HNC patients

    Treatment Modalities of Head and Neck Cancer

    1 year

Eligibility Criteria

Age17 Years - 84 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population was selected from the tertiary care centre of Nepal.

You may qualify if:

  • All histologically proven cases of head and neck region.

You may not qualify if:

  • Patient's record with incomplete data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shree Birendra Hospital

Kathmandu, 977, Nepal

Location

Related Publications (1)

  • Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111.

    PMID: 16831082BACKGROUND

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Reeba Karki, MS

    Shree Birendra Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Intern Doctor

Study Record Dates

First Submitted

November 21, 2023

First Posted

November 30, 2023

Study Start

May 1, 2022

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

November 30, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

There is no plan to share the individual participant data to protect the privacy of the participants.

Locations